2020
The fidelity of implementation of recommended care for children with malaria by community health workers in Nigeria
Adeoti O, Spiegelman D, Afonne C, Falade CO, Jegede AS, Oshiname FO, Gomes M, Ajayi IO. The fidelity of implementation of recommended care for children with malaria by community health workers in Nigeria. Implementation Science 2020, 15: 13. PMID: 32131852, PMCID: PMC7057616, DOI: 10.1186/s13012-020-0968-1.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntimalarialsArtemisininsCaregiversChild, PreschoolClinical ProtocolsCommunity Health WorkersCounselingDrug Therapy, CombinationEmployee Performance AppraisalFemaleHumansImplementation ScienceInfantInservice TrainingMalariaMicrobiological TechniquesMiddle AgedNigeriaSocioeconomic FactorsConceptsCommunity health workersResource-poor settingsClinical evaluationTreatment protocolHealth workersPerformance scoresFemale community health workersHome-based caregiversMalaria treatment recommendationsUnit increaseGold standard comparatorPost-treatment counselingOverall adherenceTreatment recommendationsMalaria careBetter outcomesQuality careTotal performance scoreFidelity of implementationIntervention fidelityMean performance scoresStandard checklistHome managementMalariaGold standard
2005
Increasing Risk of 5% or Greater Unintentional Weight Loss in a Cohort of HIV-Infected Patients, 1995 to 2003
Tang AM, Jacobson DL, Spiegelman D, Knox TA, Wanke C. Increasing Risk of 5% or Greater Unintentional Weight Loss in a Cohort of HIV-Infected Patients, 1995 to 2003. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2005, 40: 70-76. PMID: 16123685, DOI: 10.1097/01.qai.0000159627.54149.2e.Peer-Reviewed Original ResearchConceptsCohort of HIVUnintentional weight lossWeight lossAntiretroviral therapyBody compositionLow CD4 cell countsHigher HIV viral loadHigher body mass indexCare of HIVHealthy Living cohortActive antiretroviral therapyCD4 cell countCombination antiretroviral therapyHIV viral loadBody mass indexRisk of deathPresence of diarrheaFederal poverty levelLiving cohortHIV infectionMass indexMost AIDSOpportunistic infectionsViral loadPatient population
2001
Do HIV Type 1 RNA Levels Provide Additional Prognostic Value to CD4+ T Lymphocyte Counts in Patients with Advanced HIV Type 1 Infection?
Arduino J, Fischl M, Stanley K, Collier A, Spiegelman D. Do HIV Type 1 RNA Levels Provide Additional Prognostic Value to CD4+ T Lymphocyte Counts in Patients with Advanced HIV Type 1 Infection? AIDS Research And Human Retroviruses 2001, 17: 1099-1105. PMID: 11522179, DOI: 10.1089/088922201316912709.Peer-Reviewed Original ResearchConceptsHIV-1 RNA levelsHIV-1 disease progressionBaseline HIV-1 RNA levelsT-lymphocyte countsT lymphocytesDisease progressionLymphocyte countRNA levelsCells/Prognostic informationHigh baseline HIV-1 RNA levelsHIV type 1 RNA levelsPlasma HIV-1 RNA levelsSubsequent HIV-1 disease progressionAdvanced HIV-1 diseaseHIV Type 1 InfectionConditional logistic regression analysisDisease progression independentHIV-1 diseaseAdditional prognostic informationAdditional prognostic valueType 1 infectionCase-control studyLogistic regression analysisClinical status
1999
Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy
Shevitz A, Knox T, Spiegelman D, Roubenoff R, Gorbach S, Skolnik P. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. AIDS 1999, 13: 1351-1357. PMID: 10449288, DOI: 10.1097/00002030-199907300-00012.Peer-Reviewed Original ResearchConceptsFat-free massActive antiretroviral therapyHAART useHIV RNAAntiretroviral therapyCohort studyViral burdenKJ/dayHIV-seropositive menCD4 cell countHIV-seropositive personsLog10 copies/Energy expenditureLarge cohort studyIndependent effectsCross-sectional analysisHIV diseaseMedication regimensViral loadCopies/Adjusted REECell countElevated REEViral replicationHAART
1998
The effect of protease inhibitors on weight and body composition in HIV-infected patients
Silva M, Skolnik P, Gorbach S, Spiegelman D, Wilson I, Fernández-DiFranco M, Knox T. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998, 12: 1645-1651. PMID: 9764784, DOI: 10.1097/00002030-199813000-00012.Peer-Reviewed Original ResearchConceptsLean body massPI therapyHIV infectionWeight gainViral loadPhysical functioningHealth perceptionBody compositionCurrent health perceptionsActive antiretroviral therapyPI treatmentProtease inhibitor therapyBody mass indexGreater weight gainHuman growth hormoneAntiretroviral therapyHIV cohortBody massInhibitor therapyMass indexOptimal therapyFat massAnabolic stimuliPatientsGrowth hormone
1988
CHOICE OF NON-STEROIDIAL ANTI-INFLAMMATORY DRUG IN PERSONS TREATED FOR DYSPEPSIA
Avila M, Walker A, Romieu I, Perera D, Spiegelman D, Jick H. CHOICE OF NON-STEROIDIAL ANTI-INFLAMMATORY DRUG IN PERSONS TREATED FOR DYSPEPSIA. The Lancet 1988, 332: 556-559. PMID: 2900932, DOI: 10.1016/s0140-6736(88)92670-0.Peer-Reviewed Original ResearchConceptsNon-steroidal anti-inflammatory drugsUlcer diseaseMost non-steroidal anti-inflammatory drugsElderly dyspeptic patientsUse of analgesicsGroup Health CooperativeUse of paracetamolAnti-inflammatory drugsAnalgesic useDyspeptic patientsHealth CooperativeInflammatory DrugsPrior useReported associationsCausal associationAnalgesicsCimetidineSimilar ageDrugsUlcersDiseaseAssociationAgeParacetamolPrior studies